Skip to main content
. 2022 Mar 17;8(4):449–460. doi: 10.1021/acscentsci.1c01479

Scheme 1. SF2a-TT15 (6, [AB(E)CD]3-TT), a Vaccine Candidate against SF2a and Synthetic Process to Achieve Its Production from TT (4) and the Linker-Equipped Oligosaccharide 2.

Scheme 1

GMBS: N-[γ-maleimidobutyryloxy]succinimide ester, HEPES: 4-(2-hydroxyethyl) piperazine-1-ethanesulfonic acid, TT: tetanus toxoid, TTMal: maleimide-modified tetanus toxoid.